Serum IgA reactivity against GroEL of Streptococcus sanguinis and human heterogeneous nuclear ribonucleoprotein A2/B1 in patients with Behçet disease

British Journal of Dermatology

Volumn 168, Issue 5, 2013, Pages 977-983

  Cho, S B ^a   Zheng, Z ^a   Ahn, K J ^b   Choi, M J ^a   Cho, S ^a   Kim, D Y ^a   Lee, H S ^c   Bang, D ^a  

^a Cutaneous Biology Research Institute   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Jeju National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONIN 60; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN B1; IMMUNOGLOBULIN A ANTIBODY; STREPTOCOCCUS ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SEQUENCE; ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SEQUENCE ALIGNMENT; STREPTOCOCCUS SANGUINIS; WESTERN BLOTTING;

ADULT; BACTERIAL PROTEINS; BEHCET SYNDROME; CASE-CONTROL STUDIES; CHAPERONIN 60; EPITOPES; FEMALE; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HUMANS; IMMUNOGLOBULIN A; IMMUNOPRECIPITATION; MALE; MIDDLE AGED; STREPTOCOCCUS SANGUIS;

EID: 84876991282     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12128     Document Type: Article

References (33)

1. Sakane T, Takeno M, Suzuki N, et al. Behçet's disease. N Engl J Med 1999; 341: 1284-91.
2. Sohn S, Lee ES, Bang D, Lee S,. Behçet's disease-like symptoms induced by the herpes simplex virus in ICR mice. Eur J Dermatol 1998; 8: 21-3.
3. Okota K, Hayashi S, Araki Y, et al. Characterization of Streptococcus sanguis isolated from patients with Behçet's disease. Microbiol Immunol 1995; 39: 729-32.
4. Yokota K, Oguma K,. IgA protease produced by Streptococcus sanguis and antibody production against IgA protease in patients with Behçet's disease. Microbiol Immunol 1997; 41: 925-31.
5. Kaneko F, Oyama N, Yanagihori H, et al. The role of streptococcal hypersensitivity in the pathogenesis of Behçet's disease. Eur J Dermatol 2008; 18: 489-98.
6. Cho SB, Cho S, Bang D,. New insights in the clinical understanding of Behçet's disease. Yonsei Med J 2012; 53: 35-42.
7. Lee KH, Chung HS, Kim HS, et al. Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease. Arthritis Rheum 2003; 48: 2025-35.
8. Cho SB, Lee JH, Ahn KJ, et al. Identification of streptococcal proteins reacting with sera from Behçet's disease and rheumatic disorders. Clin Exp Rheumatol 2010; 28: S31-8.
9. Cho SB, Ahn KJ, Kim DH, et al. Identification of HnRNP-A2/B1 as a target antigen of anti-endothelial cell IgA antibody in Behçet's disease. J Invest Dermatol 2012; 132: 601-8.
10. Dreyfuss G, Kim VN, Kataoka N,. Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol 2002; 3: 195-205.
11. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-80.
12. Perkins DN, Pappin DJ, Creasy DM, et al. Probability-based protein identification by searching sequence database using mass spectrometry data. Electrophoresis 1999; 20: 3551-67.
13. Notredame C, Higgins DG, Heringa J,. T-Coffee: a novel method for fast and accurate multiple sequence alignment. J Mol Biol 2000; 302: 205-17.
14. Markova-Raina P, Petrov D,. High sensitivity to aligner and high rate of false positives in the estimates of positive selection in the 12 Drosophila genomes. Genome Res 2011; 21: 863-74.
15. Quinn A, Shinnick TM, Cunningham MW,. Anti-Hsp65 antibodies recognize M proteins of group A streptococci. Infect Immun 1996; 64: 818-24.
16. Marino Gammazza A, Bucchieri F, Grimaldi LM, et al. The molecular anatomy of human Hsp60 and its similarity with that of bacterial orthologs and acetylcholine receptor reveal a potential pathogenetic role of anti-chaperonin immunity in myasthenia gravis. Cell Mol Neurobiol 2012; 32: 943-7.
17. Wu CT, Ou LS, Yeh KW, et al. Serum heat shock protein 60 can predict remission of flare-up in juvenile idiopathic arthritis. Clin Rheumatol 2011; 30: 959-65.
18. Bodnár N, Szekanecz Z, Prohászka Z, et al. Anti-mutated citrullinated vimentin (anti-MCV) and anti-65 kDa heat shock protein (anti-hsp65): new biomarkers in ankylosing spondylitis. Joint Bone Spine 2012; 79: 63-6.
19. Lehner T, Lavery E, Smith R, et al. Association between the 65-kilodalton heat shock protein, Streptococcus sanguis and the corresponding antibodies in Behçet's syndrome. Infect Immun 1991; 59: 1434-41.
20. Mizushima Y, Matsuda T, Hoshi K, et al. Induction of Behçet's disease symptoms after dental treatment and streptococcal antigen skin test. J Rheumatol 1988; 15: 1029-30.
21. The Behçet's Disease Research Committee of Japan. Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behçet's disease-a multicentre study. J Rheumatol 1989; 16: 506-11.
22. Kaneko F, Oyama N, Nishibu A,. Streptococcal infection in the pathogenesis of Behçet's disease and clinical effects of minocycline on the disease symptoms. Yonsei Med J 1997; 38: 444-54.
23. Lehner T,. The role of heat shock protein, microbial and autoimmune agents in the etiology of Behçet's disease. Intern Rev Immunol 1997; 14: 21-32.
24. Kaneko S, Suzuki N, Yamashita N, et al. Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behçet's disease (BD) in Japan. Clin Exp Immunol 1997; 108: 204-12.
25. Kibaroglu A, Ekşioǧlu-Demiralp E, Akoglu T, et al. T and NK cell subset changes with microbial extracts and human HSP60-derived peptides in Behçet's disease. Clin Exp Rheumatol 2004; 22: S59-63.
26. Pervin K, Childerstone A, Shinnick T, et al. T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease. J Immunol 1993; 151: 2273-82.
27. Hasan A, Childerstone A, Pervin K, et al. Recognition of a unique peptide epitope of the mycobacterial and human heat shock protein 65-60 antigen by T cells of patients with recurrent oral ulcers. Clin Exp Immunol 1995; 99: 392-7.
28. Direskeneli H, Hasan A, Shinnick T, et al. Recognition of B-cell epitopes of the 65 kDa HSP in Behçet's disease. Scand J Immunol 1996; 43: 464-71.
29. Ergun T, Ince U, Ekşioǧlu-Demiralp E, et al. HSP 60 expression in mucocutaneous lesions of Behçet's disease. J Am Acad Dermatol 2001; 45: 904-9.
30. Deniz E, Guc U, Buyukbabani N, Gul A,. HSP 60 expression in recurrent oral ulcerations of Behçet's disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 110: 196-200.
31. Saruhan-Direskeneli G, Celet B, Ekşioǧlu-Demiralp E, Direskeneli H,. Human HSP 60 peptide responsive T cell lines are similarly present in both Behçet's disease patients and healthy controls. Immunol Lett 2001; 79: 203-8.
32. Tsan MF, Gao B,. Heat shock proteins and immune system. J Leukoc Biol 2009; 85: 905-10.
33. van Eden W, Spiering R, Broere F, van der Zee R,. A case of mistaken identity: HSPs are no DAMPs but DAMPERs. Cell Stress Chaperones 2012; 17: 281-92.